Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 3 |
2023 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Long non-coding RNAs associated with transcriptomic signatures and treatment outcome in diffuse large B-cell lymphoma.
Br J Haematol. 2023 Jul;202(2):440-444. doi: 10.1111/bjh.18870. Epub 2023 May 15.
Br J Haematol. 2023.
PMID: 37190862
No abstract available.
Single-cell profiling reveals the importance of CXCL13/CXCR5 axis biology in lymphocyte-rich classic Hodgkin lymphoma.
Aoki T, Chong LC, Takata K, Milne K, Marshall A, Chavez EA, Miyata-Takata T, Ben-Neriah S, Unrau D, Telenius A, Boyle M, Weng AP, Savage KJ, Scott DW, Farinha P, Shah SP, Nelson BH, Steidl C.
Aoki T, et al.
Proc Natl Acad Sci U S A. 2021 Oct 12;118(41):e2105822118. doi: 10.1073/pnas.2105822118.
Proc Natl Acad Sci U S A. 2021.
PMID: 34615710
Free PMC article.
Item in Clipboard
Genomic Testing for Relapsed and Refractory Lymphoid Cancers: Understanding Patient Values.
Costa S, Regier DA, Raymakers AJN, Pollard S.
Costa S, et al.
Patient. 2021 Mar;14(2):187-196. doi: 10.1007/s40271-020-00448-1.
Patient. 2021.
PMID: 32875479
Free PMC article.
Item in Clipboard
Molecular attributes underlying central nervous system and systemic relapse in diffuse large B-cell lymphoma.
Isaev K, Ennishi D, Hilton L, Skinnider B, Mungall KL, Mungall AJ, Bakhtiari M, Tremblay-LeMay R, Silva A, Ben-Neriah S, Boyle M, Villa D, Marra MA, Steidl C, Gascoyne RD, Morin R, Savage KJ, Scott DW, Kridel R.
Isaev K, et al.
Haematologica. 2021 May 1;106(5):1466-1471. doi: 10.3324/haematol.2020.255950.
Haematologica. 2021.
PMID: 32817292
Free PMC article.
No abstract available.
Item in Clipboard
TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma.
Ennishi D, Healy S, Bashashati A, Saberi S, Hother C, Mottok A, Chan FC, Chong L, Abraham L, Kridel R, Boyle M, Meissner B, Aoki T, Takata K, Woolcock BW, Viganò E, Gold M, Molday LL, Molday RS, Telenius A, Li MY, Wretham N, Dos Santos N, Wong M, Viller NN, Uger RA, Duns G, Baticados A, Madero A, Bristow BN, Farinha P, Slack GW, Ben-Neriah S, Lai D, Zhang AW, Salehi S, Shulha HP, Chiu DS, Mostafavi S, Gerrie AS, Huang DW, Rushton C, Villa D, Sehn LH, Savage KJ, Mungall AJ, Weng AP, Bally MB, Morin RD, Cohen Freue GV, Staudt LM, Connors JM, Marra MA, Shah SP, Gascoyne RD, Scott DW, Steidl C.
Ennishi D, et al.
Nat Med. 2020 Apr;26(4):577-588. doi: 10.1038/s41591-020-0757-z. Epub 2020 Feb 24.
Nat Med. 2020.
PMID: 32094924
Free PMC article.
Item in Clipboard
Cite
Cite